Author Archives: Scalper1

Allergan, Pfizer In Buyout Talks; Wall Street Cheers

Specialty drugmaker Allergan (AGN) confirmed Thursday that it’s in “preliminary friendly discussions” on a possible buyout by big pharma Pfizer (PFE), as Wall Street poured on favorable opinions of the combination. Late Wednesday, an anonymously sourced report in the Wall Street Journal said that Pfizer and Allergan were in buyout talks, setting off a round of speculation and calculation. The news wasn’t totally shocking, since Pfizer CEO Ian Read

Apple Scaling China’s Great Wall Of Smartphone Sales

China is becoming increasingly important for high-end smartphone makers, and it’s a market where Apple (AAPL) iPhones are gaining traction. But also gaining are local rivals like Huawei, its latest quarterly report shows, and Xiaomi — while top global maker Samsung hit a speed bump in high-end smartphone sales in its quarterly report Thursday. In an iconic moment, Apple CEO Tim Cook recently shared a photo of himself standing on the Great Wall of

F5 Networks’ Light Guidance, Sales Miss Hit Stock

F5 Networks (FFIV) plunged early Thursday after the company’s fiscal Q4 revenue missed expectations and it disappointed with its current-quarter guidance. Late Wednesday, Seattle-based F5 Networks said September-quarter EPS rose 17% to $1.84 per share, with revenue growing 8% to $501 million. Analysts polled by Thomson Reuters had modeled profit of $1.74 per share and $506.5 million in revenue. The maker of data center gear said it expects fiscal